21h
New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development
How People, Process, and Systems Transform the Business of Life Sciences” by Gary K. Zammit, PhD, is released with Forbes ...
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
The "The FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ResearchAndMarkets.com's offering.
The Well News on MSN
FDA to Streamline Approvals for Less Expensive, Generic Biologic Drugs
WASHINGTON - The Food and Drug Administration announced Wednesday that it plans to streamline the approval process for cheaper, "biosimilar" alternatives to biologic drugs in an effort to reduce ...
(CNN) — The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Lawmakers at the helm of the Senate Special Committee on ...
DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...
A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...
According to Nova One Advisor, the U.S. generic drugs market size is expected to be worth around 196.90 billion by 2034, increasing from USD 138.24 billion in 2024, representing a healthy CAGR of 3.6% ...
Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. For most people, medicines are a bottle of pills on a shelf — made by ...
Andrew Nixon, a spokesperson for the Health and Human Services Department, stated that the “FDA has very limited discretion” when it comes to deciding to approve a generic drug, NBC News reported. “By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback